Overview
Private equity firm investing in healthcare services and IT.
Founded
2000
Deals · 12mo
1
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
- GeoH
Led · Equity · Sep 2025
GeoH delivers a hybrid software-and-services solution that enables home-care agencies to manage staff scheduling, support clients, and handle billing within a single platform. Its end-to-end system combines practice-management tools with revenue-cycle and executive-management services, positioning the company as a full-service partner rather than a pure software vendor. GeoH reports that its revenue-cycle and executive-management offerings have helped customer agencies secure more than $275 million in funding to date, highlighting tangible value creation for its users. The company is led by CEO Tom Bumgardner and is headquartered in Indianapolis, Indiana. With the newest capital infusion, management plans to accelerate product development and scale operational capacity. While detailed financials such as annual revenue or user count were not disclosed, the sizable growth round suggests meaningful market traction and investor confidence in GeoH’s business model.
- StrataPT
Led · Equity · Oct 2024
StrataPT offers a SaaS platform that combines electronic medical records (EMR), revenue cycle management (RCM), billing, and collections into a single solution for outpatient therapy practices. The product is designed to accelerate billing and improve cash flow, helping practices realize a nearly 100% reimbursement rate. The company publishes aggregate data and analysis on reimbursement rates and benchmarks across states and practices. StrataPT is led by CEO Paul Singh and founder Kim Peacock. The company plans to use newly raised funds to expand operations and broaden its business reach. Its stated focus is reducing administrative burden so practitioners can concentrate on patient care.
- Wealth Access
Participated · Equity · Apr 2014
Wealth Access offers a proprietary, cloud-based platform that aggregates data from more than 20,000 financial services institutions and various holdings to deliver an aggregated view for high-net-worth advisors and investors. The platform is used for decision support across investments, tax planning, insurance and other complex situations faced by high-net-worth individuals. The company recently released a fund reporting system enabling limited partners to receive up-to-date, transparent reporting on private equity investments, including portfolio company valuations and electronic delivery of tax documents such as K-1s. Wealth Access is led by CEO and Founder David Benskin and is backed by Black Diamond Performance Reporting, Investment Scorecard, Square, Cultivation Capital, Cap Gemini and other wealth management technology platforms. The company received an investment from Cultivation Capital; the amount of the deal was not disclosed. The funding included board involvement from Cultivation Capital, as General Partner Rick Holton joined Wealth Access' Board of Directors. Wealth Access offers a proprietary, diagnostic software platform that aggregates data from more than 20,000 financial services institutions to deliver a consolidated view for advisors and wealthy clients. The product is a mobile-enabled financial dashboard designed to improve advisor-client collaboration and decision support across investments, tax planning, insurance and other complex financial matters. The company says it differentiates advisors by strengthening client relationships and improving the customer experience. Wealth Access has grown its team with experienced company builders and plans to use new funding to accelerate growth and deepen product development. The firm is a member of the SixThirty FinTech Accelerator in St. Louis, which the company cites as a source of strategic investor partnerships. The article is dated from Nashville, Tenn., and describes the company as three years old at the time.
- emids
Led · Equity · Dec 2013
emids provides digital engineering and transformation solutions to payers, providers, health technology companies, and life sciences firms, including custom application development, data engineering, business intelligence, and specialized consulting. The company helps clients manage complex data ecosystems to drive accessible, affordable, and high-quality healthcare. emids is headquartered in Nashville and employs over 2,200 professionals globally. The firm plans to broaden its work with health plans and deepen partnerships with Blue Cross and Blue Shield companies. emids leverages strong domain expertise in healthcare platforms, regulations, and standards to deliver tailored digital solutions. The company positions itself as a preferred partner for digital transformation across the healthcare ecosystem. emids Technologies delivers Healthcare Information Technology (HIT) and Business Process Outsourcing (BPO) services, leveraging focused healthcare domain expertise, a global delivery methodology, and partnerships with leading technology providers. The company positions itself as a scalable services platform tailored to healthcare organizations and is led by President and CEO Saurabh Sinha. emids has experienced sustained rapid growth, reporting revenue growth at a compound annual growth rate of more than 40% over the past five years. The company plans to continue rapid organic growth and pursue selective acquisitions to broaden its suite of services. Recent financing is intended to enable expansion into additional growth areas and to strengthen its market position. emids uses its delivery model to provide high-quality, cost-optimized services to the healthcare universe.
- REACH Health
Participated · Equity · Jun 2013
REACH Health provides clinically driven telemedicine software that integrates real-time audio/video technology with vital patient information, images, workflow and documentation. Its single, multidiscipline platform supports specialties including neurology, cardiology, pulmonology, psychiatry and stroke and enables remote consultations and specialist access. The company pioneered telestroke and says its solutions help health systems achieve measurable clinical, operational and financial improvements. REACH Health powers many of the nation’s largest telemedicine networks and emphasizes ease of use for physicians and clinicians across specialties. The company is rolling out its REACH Access platform to expand specialty coverage and adoption. Recent funding will support that rollout and broader growth as more health systems implement its solutions to improve outcomes and reduce costs. REACH Health offers a cloud-computing telemedicine platform that enables live audio/video consultations and comprehensive patient data sharing to connect specialty physicians with patients. Its new multidisciplinary platform, REACH Access™, was designed by physicians to extend the company’s original urgent-stroke care technology across multiple clinical disciplines. The platform was originally developed to provide remote urgent neurological care for stroke victims in remote, rural, and underserved areas. REACH’s solutions serve numerous clinical environments, including emergency departments, ICUs, clinics, and in-patient facilities for neurology, pulmonology, cardiology, psychiatry and other consultations. The company says the funding will support expansion into additional markets as more hospitals implement its telemedicine offerings. REACH Health is based in Alpharetta, Ga. REACH Call offers a Software-as-a-Service telemedicine platform that lets specialists (notably neurologists) evaluate and diagnose patients 24/7 in remote, underserved and urban locations. Its evidence-based software protocols enable clinically rich collaborations in time-critical emergency situations such as stroke, regardless of distance. The company was founded in 2006 by a group of neurology and emergency medicine physicians from Georgia Health Sciences University and is based in Augusta, GA. REACH serves hospitals within large health systems, including HCA, Ascension Health, OhioHealth and Ochsner Health System. The business recently completed a $5M Series A financing to support continued expansion into acute care services. REACH plans to grow national sales and marketing and invest in R&D to expand into new clinical specialties.
